Health Care Current library

This weekly series explores breaking news and developments in the US health care industry; examines key issues facing life sciences and health care companies; and provides updates and insights on policy, regulatory, and legislative changes.


A Challenging Future for Biopharma Innovation

A Deloitte study shows that the overall rate of return on R&D investment for the 12 largest biopharmaceutical firms has dropped significantly since 2010.


ConvergeHEALTH by Deloitte

Learn how ConvergeHEALTH can support your organization’s goals and capabilities for healthcare transformation through videos from ConvergeHEALTH.


Health Care Blog

Read the Center for Health Solutions blog, sharing timely insights, research, and forward thinking for the life sciences and health care industry.


Health Care Reform

Redefining Biopharma Innovation

Health Care Reform has increased focus on reducing cost while increasing quality of care, forcing a new definition of innovation to emerge for biopharma.

Explore Content

Health care reform encompasses legislation that has been signed in the recent past related to the access and delivery of healthcare, notably the Affordable Care Act (ACA) passed in 2010, as well as broader, nonreversible trends in the market. Reform culminates into a heightened focus on reducing cost while increasing the quality of care, which will likely force a new definition of innovation to emerge for biopharma. Historically, biopharma manufacturers and regulators have treated new molecular entity (NME) approvals as “innovative.” However, new demands from health plans and health care providers to improve the quality of care without increasing overall health care cost will increase the demand for products that demonstrate improvements in health outcomes over existing treatments.

Download the report for more information.

More topics


ConvergeHEALTH by Deloitte

ConvergeHEALTH brings together analytics platforms and data models, enabling health care and life sciences organizations to answer the “hard questions.”


Medical Technology

Deloitte’s experienced practitioners and innovative solutions can help med tech companies solve complex business challenges and create value.



Deloitte helps Generics drug manufacturers solve their toughest challenges, anticipate their next big opportunity, and achieve lasting results.



Helping BioPharma companies lead and shape the global life sciences marketplace.


About the Deloitte Center for Health Solutions

About the Deloitte Center for Health Solutions: The source for health care insights.

Ralph Marcello

Life Sciences | Strategy & Operations

Greg Reh

US life sciences sector leader

Dbriefs Webcast

Health Sciences

Anticipating tomorrow's complex issues and new strategies is a challenge. Take the lead with Dbriefs—live webcasts that give you valuable insights on important developments affecting your business. Dbriefs offers live webcasts featuring practical knowledge from Deloitte specialists.